rnA sequencing (rnA-seq) offers a snapshot of cellular rnA populations, but not temporal information about the sequenced rnA. here we report timelapse-seq, which uses oxidativenucleophilic-aromatic substitution to convert 4-thiouridine into cytidine analogs, yielding apparent u-to-c mutations that mark new transcripts upon sequencing. timelapse-seq is a single-molecule approach that is adaptable to many applications and reveals rnA dynamics and induced differential expression concealed in traditional rnA-seq.
Global changes in transcription can occur on the timescale of minutes to hours in many mammalian systems, including circadian rhythms and the immune response. One can identify such changes by monitoring new transcripts that cofractionate with chromatin 1, 2 or that have not yet been spliced 3, 4 . New RNA populations can also be identified by examining sites of active RNA polymerase II through biochemical enrichment of transcripts that are being synthesized (e.g., PRO-seq 5 and NET-seq 6 ) or metabolic labeling and enrichment of new transcripts (e.g., TT-seq 7 and s 4 U-seq 8, 9 ) . These techniques require large amounts of input sample and extensive handling, and they present challenges when normalizing enrichment and estimating contamination.
To capture temporal information about RNA directly in a sequencing experiment without biochemical enrichment, we developed TimeLapse-seq ( Fig. 1a) , a method in which cells are exposed to a noncanonical nucleoside that becomes incorporated into only new transcripts.
results development of timelapse chemistry
Rather than enriching the metabolically labeled RNAs, we developed chemistry that recodes the hydrogen-bonding pattern of the uridine analog 4-thiouridine (s 4 U) to match the hydrogen-bonding pattern of cytosine, thereby causing mutations in a sequencing experiment. This strategy is similar to bisulfite sequencing, which uses chemically induced mutations to recode nucleobase hydrogen bonding to provide insight into DNA methylation. In our strategy, the recoded nucleosides distinguish which RNAs were transcribed during the time of the experiment. TimeLapse-seq timelapse-seq: adding a temporal dimension to rnA sequencing through nucleoside recoding results are internally normalized, as both pre-existing and new transcripts are present in the same library. These mutations reveal which RNAs were recently synthesized by the cell, thereby capturing the rich dynamics of the transcriptome.
To develop TimeLapse-seq we focused on s 4 U because of its utility in RNA metabolic labeling experiments 10, 11 and the orthogonal reactivity of its thione relative to other functional groups found in RNA. The s 4 U base itself leads to low levels of U-to-C transitions upon reverse transcription 12 , but does so at levels too low to robustly identify new transcripts. While recent applications of s 4 U have focused on the thione as a nucleophile 8 , or for UV cross-linking 11, 13 , we were inspired by less explored reactivity-transforming s 4 U using oxidative-nucleophilic-aromatic substitution 14 . We reasoned that oxidation of s 4 U would transform it into a convertible nucleoside, providing an intermediate that could be converted into an analog of cytosine by aminolysis (Fig. 1a) . The s 4 U base retains uridine's Watson-Crick hydrogen-bonding pattern, and while other chemical conditions used to modify s 4 U (e.g., alkylation) change the base's hydrogen bonding pattern, they do not recode the base to match C's native hydrogen-bonding pattern. While not widely explored, the oxidative reactivity of s 4 U has precedent in UV-cross-linking studies, where sites of s 4 U-protein crosslinks are enriched for T-to-C mutations, or in mapping the locations of s 4 U bases in Escherichia coli tRNA 11, 15 . If conducted before an RNAseq analysis, this reaction could reveal sites of s 4 U incorporation through T-to-C mutations stably introduced in the cDNA.
We explored chemistry to convert the free nucleoside (s 4 U) to cytidine derivatives ( Fig. 1a and Supplementary Fig. 1 ) while minimizing oxidation of guanosine ( Supplementary Fig. 2 ) and using amines with low pK a values that remain deprotonated under neutral reaction conditions. We found that treating s 4 U with 2,2,2-trifluoroethylamine (TFEA) and meta-chloroperoxybenzoic acid (mCPBA) results in near-complete consumption of s 4 U, producing only small amounts of the hydrolysis product uridine, and mostly the desired trifluoroethylated cytidine (C*, Supplementary Fig. 3a) . Similar conditions were successful in the context of an oligoribonucleotide. Optimization of the nucleophile, oxidant, temperature, and time through a restriction-enzyme-digestion assay (see Online Methods, monitoring global steady-state rnA turnover To examine the dynamics of cellular RNAs, we treated MEF cells with s 4 U for 1 h (where no s 4 U toxicity was observed; Supplementary Fig. 6a-c) and performed TimeLapse chemistry before sequencing. The total transcript counts from each sample were highly correlated irrespective of s 4 U exposure or chemical treatment (Pearson's r ≥ 0.97, Supplementary Fig. 6d ), demonstrating that TimeLapse-seq retains information from a traditional RNA-seq experiment. By counting the mutations in each aligned read pair, we found a specific and reproducible increase in T-to-C mutations dependent on both metabolic labeling with s 4 U and chemical treatment ( Supplementary Figs. 7 and 8 ).
Other mutation rates remained below background levels of Tto-C mutations in untreated samples (e.g., the small increase in G-to-T mutations, Supplementary Fig. 2c,d) . Additionally, the reaction was efficient even in regions of RNA secondary structure ( Supplementary Fig. 9 ). The T-to-C mutation counts were dramatically higher in fast-turnover transcripts (e.g., Myc and Fosl2), compared to more stable transcripts (e.g., Dhx9 and Ybx1) ( Fig.  2a,b and Supplementary Fig. 10 ). We observed an enrichment of T-to-C mutations in intronic reads ( Fig. 2c ) consistent with the fast turnover of intronic RNA. To quantify these results, we modeled reads as arising from two populations: pre-existing RNAs (background mutation rate) and new RNAs (high T-to-C mutation rate; Fig. 2b ; see Online Methods). Reads from newly synthesized RNAs had an average of 2.2 mutations per read, corresponding to an ~3% mutation rate per uridine (compared to ~0.1% T-to-C mutation rates in controls and for pre-existing RNAs). From each gene, we determined the fraction of newly made transcripts (r ≥ 0.94; 2,992 genes; Supplementary Table 2 ) and estimated transcript half-lives, which correlated with those reported previously 17 (Supplementary Fig. 11 ). As expected, the fast-turnover RNAs (top 10%, n = 360) were enriched for transcripts such as transcription factors (Results from PANTHER analysis: DNA-templated transcription, P < 10 −20 ), while the slow-turnover RNAs (top 10%, n = 361) were enriched for those that are involved in translation (Results from PANTHER analysis: ribosomal biogenesis, P < 10 −6 ; translation, P < 10 −27 ). Estimates of the fraction of newly synthesized RNA were particularly robust when the new transcripts represented ~200 reads in the experiment ( Supplementary Fig. 12 and Supplementary Note).
distinguishing transient transcripts from contaminating reads
Very transient RNA species, such as reads beyond the poly-A termination signal in a gene body, provide insight into transcriptome dynamics but are generally too rare to be observed at high levels by RNA-seq. While these dynamics can be studied through biochemical enrichment of very recently made RNAs after short (5 min) s 4 U treatments through transient transcriptome sequencing (TT-seq 7 ), biochemically enriched s 4 U-RNA always contains contaminating reads from unlabeled RNAs (estimated to be up to 30% in some experiments 12 ). This contaminating background can limit analyses; for example, abundant spliced transcripts observed in RNA enriched after short s 4 U pulses have been interpreted as fast splicing 18 , but these results could also be explained by contaminating background (e.g., from fully spliced mature RNAs). To test if TimeLapse chemistry could be used in conjunction with TT-seq to distinguish bona fide new RNAs from contaminating background, K562 cells were labeled for 5 min with s 4 U, and biochemical enrichment was performed as in TT-seq 7 , except with more efficient MTS chemistry to biotinylate the s 4 U-RNA 9 (Supplementary Fig. 13a ). After enrichment and before sequencing, we performed TimeLapse chemistry. As expected, transient RNA species were enriched for introns (two-sample Kolmogorov-Smirnov test, P < 10 −15 ; Fig. 2d-f and Supplementary Fig. 13 ) but depleted for splice junctions (P < 10 −15 ). Both enrichment of introns and depletion of splice junctions were slightly greater than previously observed 7 (Supplementary Fig. 13c,d) , which was likely due to the efficiency of MTS chemistry. Even with only 5 min of s 4 U treatment, the majority of the biochemically enriched reads contained TimeLapse-induced mutations ( Fig. 2d) . Mutation-containing reads represented a subpopulation that was further enriched for introns and depleted for splice junctions ( Fig. 2e,f and Supplementary Fig. 13c,d ). This suggests that mutated reads effectively capture the profile of new RNAs, while the reads without mutations represent a subpopulation that is contaminated by unlabeled reads. We estimated that 15-20% of total TT-seq reads arise from contaminating RNA (estimate from splice-junction content, 17-20%; from intronic content, 18-20%; see Online Methods), similar to estimates from previous s 4 U experiments 12 . Reads without mutations were enriched for contaminating reads (estimate from splice junctions, 33-39%; estimate from introns, 35-40%), while reads containing mutations are depleted in contamination. For reads with a single mutation, contaminating reads make up <5% of the signal; for reads with two mutations, the contamination is <1%. Taken together, RNA contamination contributes to the signal at the level of RNA-seq, but TimeLapse-chemistry-induced mutations can be used to discriminate between signal from new RNAs and contaminating reads. These results demonstrate transcripts including ACTB (Supplementary Fig. 13b ) are not highly spliced on this timescale (5 min) and highlight how TimeLapse chemistry can provide an extra specificity filter when analyzing rare, transient RNAs.
identifying acute transcriptional changes with timelapse-seq
To test whether TimeLapse-seq could reveal induced changes in RNA populations, we subjected MEF cells to a mild heat shock (42 °C, 1 h), where only modest changes in total RNA levels were apparent [19] [20] [21] . We observed induction of a few transcripts such as Hspa1b by RNA-seq ( Supplementary Fig. 14a ), but TimeLapseseq revealed the induction of many transcripts encoding heat shock proteins in the new transcript pool that are not apparent by RNA-seq alone ( Fig. 2g and Supplementary Fig. 14) . For example, whereas RNA-seq is less sensitive to the small absolute changes in Hsph1 and Hsp90aa1 (as they are already abundant before heat shock; RNA-seq fold-change, Hsph1 = 1.8-fold, Hsp90aa1 = 1.1-fold, DEseq2), TimeLapse-seq reveals substantial induction of both transcripts in the new transcript pool (TimeLapse-seq fold change, Hsph1 = 12.7-fold; Hsp90aa1 = 3.1fold, DEseq2) ( Fig. 2h) . Unlike PRO-seq and NET-seq, however, which are not sensitive to changes in RNA populations after transcription has completed, TimeLapse-seq captures changes in RNA processing-we observed the induction of a new terminal exon in Rsrp1 upon heat shock ( Supplementary Fig. 14c,d) as well as post-transcriptional down-regulation of histone mRNAs upon heat shock ( Supplementary Fig. 14f,g) , neither of which would be apparent from analysis of nascent RNA.
discovering isoform-specific transcript dynamics
We applied TimeLapse-seq using treatment conditions optimized for studying mRNA turnover (4-h s 4 U) 22 in a chronic myelogenous leukemia model cell line (K562). We obtained highly reproducible half-life estimates that correlated with previous observations 23 (Supplementary Fig. 11 ). Inspection of individual transcripts revealed reads mapping to both a shorter isoform of ASXL1 (NM_001164603), as well as a longer isoform (NM_ 015338) of ASXL1. The ASXL1 protein is involved in epigenetic regulation of chromatin, and mutations in the longer isoform of this gene are implicated in myelodysplastic syndromes (MDSs) 24 . Analysis of the mutational content of the individual exons from ASXL1 demonstrated that reads mapping to the longer isoform had substantially greater turnover than those mapping to the first four exons (Figs. 3a,b) , a conclusion supported by transcriptional inhibition (Supplementary Fig. 15b,c) . The different stability of ASXL1 isoforms is particularly intriguing given the importance of RNA processing to many pathologies, including MDS 25 .
discussion
TimeLapse-seq is a single-molecule approach to monitor transcriptome dynamics. The method reveals different rates of RNA turnover, changes in RNA processing, and acute changes in the transcriptome that are not apparent using standard RNA-seq. TimeLapse-seq is conceptually similar to SLAM-seq 26 , a method that was reported during the revision of this manuscript. Whereas SLAM-seq uses alkylation of the s 4 U thione to induce mutations, TimeLapse-seq instead uses an oxidative nucleophilic aromatic substitution reaction to fully recode the hydrogen bonding pattern of s 4 U to match the native pattern of cytidine. TimeLapse-seq allowed us to conduct, to our knowledge, the first enrichment-free analysis RNA dynamics transcriptome wide, covering entire transcripts including their intronic sequences. TimeLapse-seq is broadly applicable to any application compatible with metabolic labeling (e.g., TT-seq). This approach provides a flexible platform to investigate dynamic biological systems.
methods
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
LC-MS analysis of nucleosides.
To a solution of s 4 U (50 µM) and ammonium bicarbonate (10 mM) was added TFEA (600 mM). mCPBA (10 mM) was dissolved in ethanol and added dropwise to the reaction mixture. After 1 h at 25 °C, the reaction was analyzed by reverse-phase LC-MS with a Hypersil GOLD column (Thermo, 3 µm, 160 × 2.1 mm) using chromatography conditions described previously 9 . Masses were collected using positive ion mode, and extracted ions were identified and integrated using Agilent MassHunter software.
Nuclear magnetic resonance analysis of nucleobase chemistry. 4-thiouracil (4.3 mg, 1 equiv) was dissolved in DMSO-d 6 , and TFEA (3.4 µl, 1.3 equiv) was added to the solution. After mixing, a solution of NaIO 4 in DMSO-d 6 (12.3 mg, 1.7 eq) was added to the nucleobase and amine solution, and the reaction was allowed to proceed at 45 °C for 4 h. 1 H NMR spectra were processed using the MestReNova software.
NotI restriction endonuclease assay. An RNA containing a single s 4 U nucleotide was in vitro transcribed (IVT) from a synthetic DNA template (see Supplementary Table 1 ) strand using T7 RNA polymerase and s 4 UTP in place of UTP for 16 h at 37 °C. The reaction mixture was treated with TURBO DNase for 1h at 37 °C. The RNA was purified using denaturing PAGE, and the resulting band was extracted by crushing the gel slice and soaking it in extraction buffer (1 mM EDTA, 1 mM DTT, 20 mM Tris, 300 mM NaOAc pH 5.2) at 4 °C for 4 h. The supernatant was passed through a 0.45 µM syringe filter, and the RNA was ethanol precipitated and washed with 75% ethanol before resuspension in nuclease-free water. IVT RNAs were screened for optimal TimeLapse chemistry as follows. RNA (120 ng) was added to a mixture of amine and water. A solution of oxidant was then added dropwise, and the reaction mixture was incubated at the temperature and time indicated (see Supplementary Fig. 4) . The RNA was then ethanol precipitated and washed three times with 75% ethanol before resuspension in nuclease-free water.
After chemical treatment, IVT RNA (50 ng) was reverse transcribed with SuperScript III according to the manufacturer's directions. The cDNA was PCR amplified for 30 cycles with a fluorescent forward primer, then it was amplified an additional 2 cycles using 1/5 of the previous PCR reaction material with nonlabeled primers. The amplified PCR product was then incubated with NotI HF for 1 h at 37 °C. The fluorescent products were visualized using native PAGE followed by scanning with a Typhoon FLA imager, and the proportion of cut product was determined relative to a positive control (with C in the RNA instead of s 4 U) using ImageJ.
Primer-extension assay. IVT RNA containing a single s 4 U nucleotide (200 ng RNA) was treated with TimeLapse chemistry and purified as described above. Chemically treated IVT RNA (34 ng) was then annealed to a Cy5 5′ end-labeled primer, and reverse transcription was performed according to manufacturer's instructions using the SmartScribe First Stand cDNA Synthesis kit (15 min). The reaction was then treated with RNase H, and the fluorescent products were visualized using urea PAGE followed by scanning with a Typhoon FLA imager. Full-length and truncated RT products were quantified by densitometry using ImageJ.
Targeted TimeLapse sequencing. MEF cells were grown at 37 °C in DMEM containing 10% FBS and 1% P/S at approximately 60% confluence, and the media was replaced with media supplemented with s 4 U (700 µM). After 2 h, the cells were rinsed with PBS, resuspended in TRIzol reagent, and stored overnight at −80 °C. Following chloroform extraction, total RNA was ethanol precipitated including 1 mM DTT to prevent oxidation of the s 4 U RNA and washed with 75% ethanol. Total RNA was resuspended and treated with TURBO DNase, then extracted with acidic phenol: chloroform:isoamyl alcohol and ethanol precipitated and washed as described above. Isolated total RNA was added to a mixture of TFEA (600 mM), EDTA (1 mM) and sodium acetate (pH 5.2, 100 mM) in water. A solution of NaIO 4 (10 mM) was then added dropwise, and the reaction mixture was incubated for 1 h at 45 °C. Potassium chloride (300 mM) and sodium acetate (pH 5.2, 300 mM) were added, and the reaction mixture was allowed to stand on ice for 10 min before centrifugation (>10,000 r.p.m., 30 min, 4 °C) to precipitate remaining periodate. The RNA in the supernatant was then ethanol precipitated and washed three times with 75% ethanol before resuspension in nuclease-free water. The chemically treated RNAs were then reverse transcribed using a mixture of mouse Actb-and Gapdh-specific mRNA RT primers (see Supplementary Table 1 ). The resulting cDNA was then amplified with Phusion polymerase using corresponding forward PCR primers to produce PCR amplicons approximately 150 nt in length. An Illumina sequencing library was constructed using the Illumina TruSeq Index adapters. Paired-end 75 bp sequencing was performed on an Illumina HiSeq 2500 instrument. Sequencing reads were trimmed to remove adaptor sequences and aligned to the mouse genome using Bowtie2 (ref. 28 ). Aligned reads were parsed to identify mutations at each nucleotide position in the Actb and Gapdh mRNAs using a published software package 29 . Raw mutation probabilities were determined by dividing the number of recorded mutation events by the number of reads at that position. Mutation probabilities were normalized to appropriate control samples and filtered by read depth (only positions with depth >3,000 were included in analyses). Analyses and figure plot generation were performed in R using the tidyverse, corrplot, and multiplot packages 30, 31 . The enrichment in mutation rates was tested for significance using a two-sided Wilcoxon test. Targeted sequencing was performed in duplicate using biologically distinct samples.
Targeted TimeLapse-seq of K562 RNA was performed similarly with the following exceptions. Cells were grown at 37 °C in RPMI containing 10% FBS and 1% P/S. At approximately 50% confluence, the media was supplemented with a range of s 4 U concentrations (10-40 µM) for 1 h. Total RNA was isolated and chemically treated as described previously. The chemically treated RNAs were then reverse transcribed using a mixture of human MYC-specific mRNA RT primers (see Supplementary  Table 1 ). A targeted sequencing library was prepared and analyzed as described above.
Cell viability. MEF cells were grown at 37 °C in DMEM containing 10% FBS and 1% P/S. Cells were plated at 10 6 cells/mL in a 96-well microtiter plate and allowed to recover overnight. Cells were then treated in triplicate with increasing concentrations of s 4 U (0-1 mM) for 1 h, and the ATCC MTT Cell Proliferation Assay kit was used according to manufacturer's instructions to assess cell viability.
Transcriptome-wide TimeLapse-seq. MEF cells were grown at 37 °C in DMEM containing 10% FBS and 1% P/S. At approximately 60% confluence, the media was replaced and supplemented with s 4 U (1 mM). The cells were incubated at 37 °C for 1 h, at which point total RNA was isolated and chemically treated as described in the targeted sequencing section. For heat shock analyses, at approximately 60% confluence, the media was replaced and supplemented with s 4 U (1 mM), and heat-shocked cells were incubated at 42 °C for 1 h. RNA was prepared as described for the Targeted TimeLapse-seq libraries. For each sample, 10 ng of total RNA was used to construct a sequencing library using the Clontech SMARTer Stranded Total RNA-Seq kit (Pico Input) with ribosomal cDNA depletion. Paired-end 100 bp sequencing was performed on an Illumina HiSeq 4000 instrument. TimeLapseseq was performed in duplicate using biologically distinct samples for experimental samples both with and without heat shock. Raw and processed sequencing data have been submitted to the GEO database.
TT-TimeLapse-seq. K562 cells were grown at 37 °C in RPMI containing 10% FBS and 1% P/S. At approximately 50% confluence, the media was supplemented with s 4 U (1 mM). The cells were incubated at 37 °C for 5 min, at which point total RNA isolation and genomic DNA depletion were performed as described above. 50 µg of total RNA was subjected to MTS chemistry, followed by biotinylation and streptavidin enrichment essentially as previously described 9 with the following modification: after SAV beads were washed three times with high-salt wash buffer (1 M NaCl, 100 mM Tris pH 7.4, 10 mM EDTA, 0.05% Tween), beads were incubated in TE buffer (10 mM Tris pH 7.4, 1 mM EDTA) at 55 °C for 15 min, followed by two washes with prewarmed 55 °C TE buffer. After elution from SAV beads, enriched RNA was purified using one equivalent volume of Agencourt RNAclean XP beads according to manufacturer's instructions instead of purification by ethanol precipitation. Enriched RNA and input RNA were chemically treated as previously described. Chemically treated RNA was purified using 1 equivalent volume of Agencourt RNAclean XP beads according to manufacturer's instructions. Purified material was then incubated in a reducing buffer (10 mM DTT, 100 mM NaCl, 10 mM Tris pH 7.4, 1 mM EDTA) at 37 °C for 30 min, followed by a second RNAclean bead purification. For each sample, all enriched material or 10 ng of total RNA input was used to construct a sequencing library using the Clontech SMARTer Stranded Total RNA-Seq kit (Pico Input) with ribosomal cDNA depletion. Paired-end 150 bp sequencing was performed on an Illumina HiSeq 4000 instrument. TimeLapse-seq was performed in duplicate using biologically distinct samples for experimental samples. Raw and processed sequencing data have been submitted to the GEO database.
Samples for TimeLapse-seq analysis of K562 mRNA. K562 cells were grown as previously described. At approximately 50% confluence, the media was supplemented with s 4 U (100 µM). The cells were incubated at 37 °C for 4 h, at which point total RNA was isolated using the RNeasy mini kit with the following modifications: buffers RLT and RPE were supplemented with 1% final 2-mercaptoethanol (BME); an additional 80% EtOH wash was performed after the RPE step; and the column was spun at maximum speed for 5 min to dry before elution with water. The isolated RNA was then chemically treated and purified as previously described. For each sample, 10 ng of total RNA was used to construct a sequencing library using the Clontech SMARTer Stranded Total RNA-Seq kit (Pico Input) with ribosomal cDNA depletion. Paired-end 150 bp sequencing was performed on an Illumina HiSeq 4000 instrument. TimeLapse-seq was performed in duplicate using biologically distinct samples for experimental samples. Raw and processed sequencing data have been submitted to the GEO database.
Transcriptional inhibition. K562 cells were grown as described above. At approximately 50% confluence, cells were treated in duplicate with actinomycin D (2 µg/mL final) for 30 min, 1 h, 3 h, 5 h, and 9 h, or left untreated. Total RNA isolation and genomic DNA depletion were then performed as previously described. RT was performed using the SuperScript VILO cDNA synthesis kit, and qPCR was performed using primers specific to ACTB, DHX9, and ASXL1. qPCR ct values for DHX9 and ASXL1 were then averaged and normalized to those of ACTB for each timepoint. The normalized fraction remaining was estimated for each primer pair by dividing the relative abundance of each timepoint by the relative abundance at t = 0.
Sequencing alignment and mutational analysis. Reads were filtered for unique sequences using FastUniq 32 , trimmed using cutadapt 33 to remove Illumina adaptor sequences filtering for reads greater than 20 nt (−minimum-length = 20) and aligned to the mouse GRCm38 or human GRCh38 genome and transcriptome annotations using HISAT2 34 , using default parameters and-mp 4,2. Files were further processed with Picard tools (http://broadinstitute.github.io/picard/) including FixMateInformation, SortSam, and BuildBamIndex. The samtools 35 software was used to retain only reads that aligned uniquely (flag: 83/163, 99/147), with MAPQ ≥ 2, and without insertions (because of ambiguity in mutational analysis) for further analysis.
Reads that uniquely map to the human GRCh38 version 26 (Ensembl 88) or mouse GRCm38 (p6) were identified using HTSeq-count using union mode 36 . Reads mapping to only mature isoforms or to anywhere in the gene body were determined separately and compared to identify intron-only reads.
To determine the number of uridine residues inferred from each read, and the sites of T-to-C mutations, the aligned bam files were processed in R using Rsamtools (http://bioconductor. org/packages/release/bioc/html/Rsamtools.html), and the sites and numbers of mutations were determined using a custom R function (available upon request). Only mutations at positions with a base quality score of greater than 45 that were at least 3 nt from the end of the read were counted. Reads were excluded where there were greater than five T-to-C mutations, and these mutations did not account for at least one-third of the observed mutations (NM tag). Without adequate filtering, SNPs could interfere with TimeLapse analysis. To identify sites of SNPs (or RNA modifications that could be misidentified as TimeLapse mutations), we used the following two strategies. First, we identified T-to-C SNP sites in control samples using bcftools 37 with default options and excluded these sites from our analysis. Second, we compiled locations where T-to-C mutations were high in non-s 4 U-treated controls and excluded these sites from analysis. Once the putative SNPs were filtered, the total number of unique mutations in each read pair was counted. To examine the distribution of reads with each minimum number of T-to-C mutations, the bam files were filtered using Picard tools. To make genome-coverage tracks, STAR aligner (inputA-lignmentsFromBam mode, outWigType bedGraph) was used, and the tracks were normalized using factors derived from RNAseq analyses using values from DESeq2 (estimateSizeFactors) 38 . Tracks were converted to binary format (toTDF, IGVtools) and visualized in IGV 39 .
Secondary structure analysis. Aligned reads from the 4h K562 TimeLapse-seq experiment overlapping the 5′ stem loop of 7SK were extracted using samtools. A Python script developed for analyses of chemical probing data (RTEventsCounter 29 ) was used to calculate the U-to-C mutation frequency for each uridine nucleotide. These frequencies were normalized by subtracting mutation frequencies of control samples that were not subjected to TimeLapse chemistry. The frequencies of mutations at each position were binned and mapped onto a conformational model of this region of human 7SK 37 . Each nucleotide was classified as either single stranded or basepaired. A twosided Wilcoxon test was used to determine the significance of differences between mutation rates of the basepaired and singlestranded nucleotides.
Estimation of the fraction of new transcripts and transcript half-lives.
Two different models were used to examine the mutation distribution in TimeLapse-seq data set: a simpler Poisson model (which does not take into account the uridine content of different reads) and a binomial model that does take the number of uridines into account. We obtained consistent results from both models. For the simpler Poisson model, for each sample (s j ), the distribution of T-to-C mutations (Y i ) was determined in each read, and the reads were grouped based on the transcripts to which they map. A negative control sample (no s 4 U treatment) was used to estimate the background rate of read pairs containing T-to-C mutations that map to each transcript. These frequencies depended on the cell line used (MEF samples required higher s 4 U treatment to obtain similar levels of mutations compared to K562 cells) as well as the sequencing experiment (different samples led to different background rates independent of chemistry or s 4 . We estimated gene-specific rates by drawing from the global mean and s.d., with a mixing rate with an uninformative prior (θ n ~Uniform(0,1)) where the mixing rate (θ n ) estimates the fraction of each transcript that was new: Attempts to model entire TimeLapse-seq data sets using this approach were computationally challenging, but we found that consistent results were obtained using 20 representative transcripts from each sample. The majority of these transcripts were chosen randomly from all reasonably expressed transcripts (>200 reads), but we included few transcripts that were hand chosen to ensure the modeling included both fast and slow turnover RNAs such as Myc and Actb. The results using 20 transcripts were consistent with results from 200 transcripts. In the case of the MEF samples shown in Figure 2 , the λ o was estimated as 0.07 mutations/read (50% credible interval 0.062-0.074), and λ n was estimated as 2.3 mutations/read (2.298 mutation/read, 50% CI 2.10-2.30 for heat shock; 2.288 mutation/read, 50% CI 1.90-2.29 for untreated).
Once these global parameters were determined, they were used to estimate the fraction of new transcripts (θ new ), using expectation maximization by minimizing the log likelihood using the nlm function in the MASS package in R: The 95% Wald confidence interval was calculated using the Hessian (nlm option hessian = TRUE), to calculate:
To ensure the mutations were both s 4 U-treatment and TimeLapse-chemistry dependent, we only included transcripts where there was sufficient data (reads > 100 counts in at least two samples), and where the fit converged (−0.05 < θ n < 1.05; hessian > 1,000). The inferred new read counts were determined by multiplying the estimated fraction of new transcripts by the total RNA-seq transcript count. Correlations between replicates were determined using the log 10 -transformed counts ( Supplementary  Fig. 8) . While the reproducibility of the data was generally high when all converged transcripts were included (Pearson's r > 0.91), filtering for transcripts with at least 75 inferred new reads provided slightly more reproducible results (n = 3,603, r = 0.934), and this filter was used for further analysis.
To account for differences in the number of uridine residues in each read pair, an alternative model was used based on the binomial distribution. Specifically, the data were modeled as mixture of two binomial distributions: where p o , p n are the probabilities of mutation at each uridine nucleotide for old and new transcripts, and n u is the number of uridines observed for read i. To determine the global mutation rate, we used Bayesian hierarchical modeling as described above for the Poisson model but using a mixture of binomial distributions. From this analysis, we estimate the background mutation rate (p o ) to be 0.0012 mutations/uridine (50% CI 0.00121, 0.00123) and the mutation rate for new reads (p n ) to be 0.0332 mutations/uridine (50% CI 0.0329, 0.0335). In other words, ~0.1% of Us are mutated to C in pre-existing reads, and in new reads ~3% of Us are mutated to C. Using these global parameters, the distributions of individual genes were fit with nlm similarly to what is described above, except by minimizing the log likelihood of the binomial model instead: ( ( ; , , ) ) , , f y p p n n o n u i i n g q 1 In addition to computing the confidence interval using the hessian, we also examined the quality of the fit by plotting the observed frequency of mutations in each replicate in the TimeLapse data (gray points in distribution plots) to a simulated distribution of the expected new and old reads based on the binomial model ( Fig. 2b and Supplementary Fig. 16 ). Estimates of the fraction new were highly similar between those determined using the binomial model and the Poisson model.
To account for any specific loss of transcripts that might arise from biased loss of s 4 U-RNA transcripts independent of TimeLapse chemistry, or TimeLapse-depended loss due to reverse-transcription termination, we developed a means of estimating the loss of fast-turnover transcripts in the data. This correction was only used when estimating transcript half-lives after observing a modest, but statistically significant loss of reads from high turnover RNAs (see Supplementary Fig. 3d) . To estimate the fraction of new reads missing, we used the R package nlm to fit the equation:
where s y and s o are scale factors that adjust for library sizes determined using DESeq2 with the total (RNA-seq) transcript counts for the experimental sample and control, respectively; N y and N o are the counts for each transcript; and θ n is the unadjusted fraction new of each transcript. This equation was fit using transcripts where 0.8 < θ n for K562 RNA, but 0.5 < θ n in the case of MEF RNA (the shorter s 4 U treatment lead to fewer transcripts with high θ n , so the threshold was lowered to increase the number of transcripts).
In the case of the comparison shown in Supplementary Figure 3d , the adjustment factor determined for chemistry-induced dropout was ~5% (i.e., x = 0.05 in the equation above, which leads a transcript with 75% new reads to be adjusted to 79% and a transcript with 25% new reads would be adjusted to 26% new reads).
The transcript half-lives were determined using the adjusted fraction of new RNA assuming a simple exponential model of their kinetics. The half-life values were compared to similar reports and the r 2 determined using the lm function in R.
Gene ontology analysis. GO analysis from the PANTHER database (version 12.0) 41 was performed using a statistical over-representation test (default parameters) on the complete biological process annotation set using the top 10% slow or top 10% fast turnovers RNAs in our 1 h MEF TimeLapse-seq data as determined by the half-life analyses described above.
Differential expression analysis. Differential expression analysis was performed using DESeq2. To examine the inferred differences in the new transcript pool based on TimeLapse mutations, we used the unadjusted estimates of the fraction of new RNA to infer the number of counts resulting from new transcripts as described above. As TimeLaspse-seq data are internally controlled, we used the size factors determined from total counts to scale each data set (i.e., we ran DESeq2 on the total RNA-seq data and used the sizeFactors function to scale the inferred new RNA counts to the RNA-seq-determined values) with default conditions including the Benjamini-Hochberg 42 adjusted P value (p adj in text). RNAseq analysis was performed on all reads (i.e., reads that had zero or more T-to-C mutations) using DESeq2 with default parameters.
Estimation of contaminating reads in TT-TimeLapse-seq.
Reads from TT-TimeLapse-seq were processed and analyzed as for TimeLapse-seq. Junction-containing reads were determined from the presence of "N" characters in the CIGAR string in the aligned bam file using bamtools (version 2.3, https://hcc-docs. unl.edu/display/HCCDOC/BamTools). The levels of contaminating reads were estimated by assuming the contaminating reads have the same ratios as RNA-seq data, and that reads with three or more mutations constitute the true ratio of reads. We use of reads with three or more mutations as true positives, because the probability of a read containing three or more mutations without s 4 U is <10 −5 . We used the fraction of intron-or junction-containing reads for the RNA-seq data (r o ), the total in the true positive population (r tp ), and the total for each population (r x ). In each analysis, we only considered reads that had nonzero ratios and ratios that were less than one. The fraction of reads from contamination (c x ) was then estimated: For comparisons with the TT-TimeLapse-seq data presented here, the data from Schwalb et al. 7 , (SRR4000390, SRR4000391 and SRR4000397) were aligned and processed using the same pipeline described for TimeLapse-seq. For this comparison, we reprocessed our TT-TimeLapse-seq data using only 75 nt of each read, and this trimming was performed on fastq files before alignment. This step was performed because the probability of a sequencing read containing a splice junction or being an intron-only read is dependent on the read length. Otherwise, all processing was handled equally between data sets.
Code availability. All software and parameters used are described above, and custom scripts and functions are available upon request.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. Data are available in the Gene Expression Omnibus (GEO) under accession number GSE95854.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly.
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. p values) given as exact values whenever possible and with confidence intervals noted A summary of the descriptive statistics, including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
